DrugPatentWatch Database Preview
Drugs in Development Information for Bardoxolone
» See Plans and Pricing
What is the development status for investigational drug Bardoxolone?
Bardoxolone is an investigational drug.
There have been 28 clinical trials for Bardoxolone.
The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2016.
The most common disease conditions in clinical trials are Kidney Diseases, Renal Insufficiency, Chronic, and Diabetes Mellitus. The leading clinical trial sponsors are Reata Pharmaceuticals, Inc., Kyowa Kirin Co., Ltd., and NYU Langone Health.
There are nineteen US patents protecting this investigational drug and seventy-four international patents.
Summary for Bardoxolone
| US Patents | 19 |
| International Patents | 74 |
| US Patent Applications | 32 |
| WIPO Patent Applications | 69 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2016-09-01) |
| Vendors | 36 |
Recent Clinical Trials for Bardoxolone
| Title | Sponsor | Phase |
|---|---|---|
| BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19) | Reata Pharmaceuticals, Inc. | Phase 2/Phase 3 |
| BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19) | NYU Langone Health | Phase 2/Phase 3 |
| Phase I Study of RTA 402 in Obese Adults | Kyowa Kirin Co., Ltd. | Phase 1 |
Clinical Trial Summary for Bardoxolone
Top disease conditions for Bardoxolone
Top clinical trial sponsors for Bardoxolone
US Patents for Bardoxolone
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Bardoxolone | Start Trial | Pyridyl analogs of 1-(2-cyano-3,12-dioxooleana-1,9(11)dien-28-oyl) imidazole | Trustees of Dartmouth College (Hanover, NH) | Start Trial |
| Bardoxolone | Start Trial | Compositions and methods for restoring the stratum corneum and treating dermatological diseases | New York University (New York, NY) BIOKEYS FOR FLAVORS, LLC (Norwood, NJ) | Start Trial |
| Bardoxolone | Start Trial | Inhibitors and methods of use thereof | The Trustees of Dartmounth College (Hanover, NH) | Start Trial |
| Bardoxolone | Start Trial | CDDO-compounds and combination therapies thereof | The Trustees of Dartmouth College (Hanover, NH) Board of Regents, The University of Texas System (Austin, TX) | Start Trial |
| Bardoxolone | Start Trial | Synthesis and biological activities of new tricyclic-bis-enones (TBEs) | Trustees of Dartmouth University (Hanover, NH) | Start Trial |
| Bardoxolone | Start Trial | CDDO-compounds and combination therapies thereof | Board of Regents, The University of Texas System (Austin, TX) The Trustees of Dartmouth College (Hanover, NH) | Start Trial |
| Bardoxolone | Start Trial | Synthesis and biological activities of new tricyclic-bis-enones (TBEs) | Trustees of Dartmouth College (Hanover, NH) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Bardoxolone
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Bardoxolone | World Intellectual Property Organization (WIPO) | WO2016033132 | 2034-08-26 | Start Trial |
| Bardoxolone | World Intellectual Property Organization (WIPO) | WO2012170467 | 2031-06-07 | Start Trial |
| Bardoxolone | Australia | AU2003303128 | 2022-05-13 | Start Trial |
| Bardoxolone | Canada | CA2485565 | 2022-05-13 | Start Trial |
| Bardoxolone | European Patent Office | EP1507541 | 2022-05-13 | Start Trial |
| Bardoxolone | Japan | JP2006515859 | 2022-05-13 | Start Trial |
| Bardoxolone | World Intellectual Property Organization (WIPO) | WO2004064723 | 2022-05-13 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
